All posts by admin

14Mar/14

Veloxis Pharmaceuticals A/S – Correction: US FDA Accepts Veloxis' New Drug … – Wall Street Journal

Veloxis Pharmaceuticals A/S – Correction: US FDA Accepts Veloxis’ New Drug
Wall Street Journal
Envarsus(R) is Veloxis’ once-daily tacrolimus based on the company’s proprietary MELTDOSE technology. Key points: — FDA has set a target review date under the Prescription Drug User Fee Act (PDUFA) of October 30, 2014 — The NDA was submitted to the 
Correction: U.S. FDA Accepts Veloxis’ New Drug Application for Envarsus® for GlobeNewswire (press release)

all 2 news articles »